Evidence map›Paper›PMID 30959771›Full record

ArticleInternational journal of molecular sciences2019

Mitochondrial Targeting of Antioxidants Alters Pancreatic Acinar Cell Bioenergetics and Determines Cell Fate.

Jane A Armstrong, Nicole J Cash, Jack C Morton, Alexei V Tepikin, Robert Sutton, David N Criddle

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Mitoquinone mesylate attenuates pathological features of lean and obese allergic asthma in mice.American journal of physiology. Lung cellular and molecular physiology · 2023
    Article
  8. Intracellular CaInternational journal of molecular sciences · 2020
    Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jane A ArmstrongDepartment of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, Liverpool L69 3BX, UK. janearm@liverpool.ac.uk.
Nicole J CashDepartment of Cellular & Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool L69 3BX, UK. Nicole.Cash@liverpool.ac.uk.
Jack C MortonDepartment of Cellular & Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool L69 3BX, UK. jmorton@liverpool.ac.uk.ORCID 0000-0002-6571-1191
Alexei V TepikinDepartment of Cellular & Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool L69 3BX, UK. kiev@liverpool.ac.uk.
Robert SuttonDepartment of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, Liverpool L69 3BX, UK. sutton@liverpool.ac.uk.
David N CriddleDepartment of Cellular & Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool L69 3BX, UK. criddle@liv.ac.uk.
University of Liverpool · GB

Funding

Department of Health EME/15/20/01Medical Research Council MR/N011384/1Wellcome Trust 102381/Z/13/Z
6 · The paper itself

Abstract

Mitochondrial dysfunction is a core feature of acute pancreatitis, a severe disease in which oxidative stress is elevated. Mitochondrial targeting of antioxidants is a potential therapeutic strategy for this and other diseases, although thus far mixed results have been reported. We investigated the effects of mitochondrial targeting with the antioxidant MitoQ on pancreatic acinar cell bioenergetics, adenosine triphosphate (ATP) production and cell fate, in comparison with the non-antioxidant control decyltriphenylphosphonium bromide (DecylTPP) and general antioxidant

Indexed as

Cell LineageEnergy MetabolismAcetylcysteineAcinar CellsAdenosine TriphosphateAnimalsAntioxidantsCell DeathCell SurvivalFlavin-Adenine DinucleotideMice, Inbred C57BLMitochondriaNADOnium CompoundsOrganophosphorus CompoundsOxidation-ReductionAcetylcysteineAdenosine TriphosphateAntioxidantsdecyltriphenylphosphoniumFlavin-Adenine DinucleotidemitoquinoneNADOnium CompoundsOrganophosphorus CompoundsUbiquinoneantioxidantsDecylTPPmitochondrial dysfunctionmitochondrial targetingMitoQoxidative stresspancreatic acinar cellSeahorse

Identifiers

PMID30959771
PMCPMC6480340
OpenAlexW2933990197

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.